Peter Kalivas to Astrocytes
This is a "connection" page, showing publications Peter Kalivas has written about Astrocytes.
Connection Strength
2.622
-
Astrocytes as cellular mediators of cue reactivity in addiction. Curr Opin Pharmacol. 2021 02; 56:1-6.
Score: 0.597
-
Gq-DREADD Selectively Initiates Glial Glutamate Release and Inhibits Cue-induced Cocaine Seeking. Biol Psychiatry. 2015 Oct 01; 78(7):441-51.
Score: 0.407
-
Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis. Neuroscientist. 2014 Dec; 20(6):610-22.
Score: 0.379
-
Bidirectional modulation of cystine/glutamate exchanger activity in cultured cortical astrocytes. Ann N Y Acad Sci. 2003 Nov; 1003:472-5.
Score: 0.186
-
Forebrain astroglial plasticity is induced following withdrawal from repeated cocaine administration. Eur J Neurosci. 2003 Mar; 17(6):1273-8.
Score: 0.177
-
Astrocyte regulation of synaptic signaling in psychiatric disorders. Neuropsychopharmacology. 2023 01; 48(1):21-36.
Score: 0.168
-
Astrocytes in the ventral pallidum extinguish heroin seeking through GAT-3 upregulation and morphological plasticity at D1-MSN terminals. Mol Psychiatry. 2022 02; 27(2):855-864.
Score: 0.161
-
Heroin Cue-Evoked Astrocytic Structural Plasticity at Nucleus Accumbens Synapses Inhibits Heroin Seeking. Biol Psychiatry. 2019 12 01; 86(11):811-819.
Score: 0.138
-
Effects of Methamphetamine Self-Administration and Extinction on Astrocyte Structure and Function in the Nucleus Accumbens Core. Neuroscience. 2019 05 15; 406:528-541.
Score: 0.135
-
Metaplasticity at the addicted tetrapartite synapse: A common denominator of drug induced adaptations and potential treatment target for addiction. Neurobiol Learn Mem. 2018 10; 154:97-111.
Score: 0.125
-
Cocaine Self-Administration and Extinction Leads to Reduced Glial Fibrillary Acidic Protein Expression and Morphometric Features of Astrocytes in the Nucleus Accumbens Core. Biol Psychiatry. 2016 08 01; 80(3):207-15.
Score: 0.108
-
Extrasynaptic therapeutic targets in substance use and stress disorders. Trends Pharmacol Sci. 2022 01; 43(1):56-68.
Score: 0.041